Results 151 to 160 of about 1,914,162 (298)

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source

Empirical insights into residual emissions in urban net-zero targets. [PDF]

Nat Clim Chang
Ulpiani G, Rodriguez Mendez Q, Todeschi V, Hernandez Moral G, Vetters N, Pittalis M, Fuss S, Gevers Deynoot C, Creutzig F.   +8 more
europepmc   +1 more source

Data‐Driven SuStaIn Model of Disability Progression in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether ordinal Subtype and Stage Inference (SuStaIn) applied to routine ALSFRS‐R item scores can identify reproducible disability progression patterns in amyotrophic lateral sclerosis (ALS) and provide clinically meaningful staging.
Giammarco Milella, Veria Vacchiano, Vittorio Velucci, Stefano Zoccolella, Rocco Liguori, Giovanni Defazio   +5 more
wiley   +1 more source

Rethinking chemical clusters: Greenfield and brownfield transition to net-zero by 2050. [PDF]

iScience
Tiggeloven JL, Faaij APC, Kramer GJ, Gazzani M.   +3 more
europepmc   +1 more source

Association Between Neurofilament Light Chain and Real‐World Ambulatory Function in Progressive MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in multiple sclerosis (MS), yet associations with functional outcomes remain unclear. Longitudinal associations between serum NfL (sNfL) and daily step count (STEPS) from wearable devices were assessed in a large international progressive MS cohort.
Gabby B. Joseph, Megan McCune, Riley Bove, Ahmed Abdelhak, Bruce A. C. Cree, Valerie J. Block   +5 more
wiley   +1 more source

Net Zero Energy Buildings (NZEB) : concepts, frameworks and roadmap for project analysis and implementation /

Net Zero Energy Buildings (NZEB): Concepts, Frameworks and Roadmap for Project Analysis and Implementation provides readers with the elements they need to understand, combine and contextualize design decisions on Net Zero Energy Buildings.
Attia, Shadyauthor.
core  

Blurring evidence with advocacy: a systematic review of policy recommendations for net zero. [PDF]

NPJ Environ Soc Sci
Danopoulos E, Shah A, Schneider CR, Aston JAD.   +3 more
europepmc   +1 more source

Clinical Impact of MGMT Promoter Methylation in IDH‐Mutant Gliomas: Influence of Threshold Selection and Clinical Confounding

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang, Linxi Cao, Xiaodong Chen, Siqi Tong, Qinghui Zhu, Jun Yang, Song Lin, Yong Cui   +7 more
wiley   +1 more source

Rapid synthesis: Achieving net-zero emissions in health systems through strategic funding partnerships and networks

An in-depth synthesis of what is known based on the best available global research evidence (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian ...
Jaspal, A, Alam, S, Moat, KA, DeMaio, P, Bain, T, Lavis, JN   +5 more
core  

Pathways to cost-optimal and net-zero emissions irrigation in the United States. [PDF]

Nat Commun
Späte J, Mingolla S, Rosa L.
europepmc   +1 more source